These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16258266)

  • 1. BRCA1 regulates gene expression for orderly mitotic progression.
    Bae I; Rih JK; Kim HJ; Kang HJ; Haddad B; Kirilyuk A; Fan S; Avantaggiati ML; Rosen EM
    Cell Cycle; 2005 Nov; 4(11):1641-66. PubMed ID: 16258266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA1 downregulation leads to premature inactivation of spindle checkpoint and confers paclitaxel resistance.
    Chabalier C; Lamare C; Racca C; Privat M; Valette A; Larminat F
    Cell Cycle; 2006 May; 5(9):1001-7. PubMed ID: 16639080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.
    Rauh-Adelmann C; Lau KM; Sabeti N; Long JP; Mok SC; Ho SM
    Mol Carcinog; 2000 Aug; 28(4):236-46. PubMed ID: 10972993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.
    Yuan B; Xu Y; Woo JH; Wang Y; Bae YK; Yoon DS; Wersto RP; Tully E; Wilsbach K; Gabrielson E
    Clin Cancer Res; 2006 Jan; 12(2):405-10. PubMed ID: 16428479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells.
    Xu X; Weaver Z; Linke SP; Li C; Gotay J; Wang XW; Harris CC; Ried T; Deng CX
    Mol Cell; 1999 Mar; 3(3):389-95. PubMed ID: 10198641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1 interaction of centrosomal protein Nlp is required for successful mitotic progression.
    Jin S; Gao H; Mazzacurati L; Wang Y; Fan W; Chen Q; Yu W; Wang M; Zhu X; Zhang C; Zhan Q
    J Biol Chem; 2009 Aug; 284(34):22970-7. PubMed ID: 19509300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1.
    Muraoka-Cook RS; Caskey LS; Sandahl MA; Hunter DM; Husted C; Strunk KE; Sartor CI; Rearick WA; McCall W; Sgagias MK; Cowan KH; Earp HS
    Mol Cell Biol; 2006 Sep; 26(17):6412-24. PubMed ID: 16914727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin B1 stability is increased by interaction with BRCA1, and its overexpression suppresses the progression of BRCA1-associated mammary tumors.
    Choi EK; Lim JA; Kim JK; Jang MS; Kim SE; Baek HJ; Park EJ; Kim TH; Deng CX; Wang RH; Kim SS
    Exp Mol Med; 2018 Oct; 50(10):1-16. PubMed ID: 30327455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
    Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
    Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1 and prostate cancer.
    Rosen EM; Fan S; Goldberg ID
    Cancer Invest; 2001; 19(4):396-412. PubMed ID: 11405179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution.
    Deng CX
    Nucleic Acids Res; 2006; 34(5):1416-26. PubMed ID: 16522651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.
    Ertych N; Stolz A; Valerius O; Braus GH; Bastians H
    Proc Natl Acad Sci U S A; 2016 Feb; 113(7):1817-22. PubMed ID: 26831064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1 is regulated by Chk2 in response to spindle damage.
    Chabalier-Taste C; Racca C; Dozier C; Larminat F
    Biochim Biophys Acta; 2008 Dec; 1783(12):2223-33. PubMed ID: 18804494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcellular localization of the BRCA1 gene product in mitotic cells.
    Lotti LV; Ottini L; D'Amico C; Gradini R; Cama A; Belleudi F; Frati L; Torrisi MR; Mariani-Costantini R
    Genes Chromosomes Cancer; 2002 Nov; 35(3):193-203. PubMed ID: 12353262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 modulates malignant cell behavior, the expression of survivin and chemosensitivity in human breast cancer cells.
    Promkan M; Liu G; Patmasiriwat P; Chakrabarty S
    Int J Cancer; 2009 Dec; 125(12):2820-8. PubMed ID: 19551867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genistein inhibits Brca1 mutant tumor growth through activation of DNA damage checkpoints, cell cycle arrest, and mitotic catastrophe.
    Tominaga Y; Wang A; Wang RH; Wang X; Cao L; Deng CX
    Cell Death Differ; 2007 Mar; 14(3):472-9. PubMed ID: 17024228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1 at the crossroad of multiple cellular pathways: approaches for therapeutic interventions.
    Yarden RI; Papa MZ
    Mol Cancer Ther; 2006 Jun; 5(6):1396-404. PubMed ID: 16818497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint.
    Wang RH; Yu H; Deng CX
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17108-13. PubMed ID: 15563594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma.
    Baldassarre G; Battista S; Belletti B; Thakur S; Pentimalli F; Trapasso F; Fedele M; Pierantoni G; Croce CM; Fusco A
    Mol Cell Biol; 2003 Apr; 23(7):2225-38. PubMed ID: 12640109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1 in hormone-responsive cancers.
    Rosen EM; Fan S; Pestell RG; Goldberg ID
    Trends Endocrinol Metab; 2003 Oct; 14(8):378-85. PubMed ID: 14516936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.